{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:13Z","timestamp":1786980493165,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T00:00:00Z","timestamp":1495584000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s10067-017-3682-x","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T11:22:13Z","timestamp":1495624933000},"page":"1997-2004","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment response to etanercept in methotrexate refractory juvenile idiopathic arthritis: an analysis of predictors and long-term outcomes"],"prefix":"10.1007","volume":"36","author":[{"given":"Yueh","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Hsu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Luen","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,24]]},"reference":[{"issue":"9783","key":"3682_CR1","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/s0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A (2011) Juvenile idiopathic arthritis. Lancet (London, England) 377(9783):2138\u20132149. doi:\n10.1016\/s0140-6736(11)60244-4","journal-title":"Lancet (London, England)"},{"issue":"2","key":"3682_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31(2):390\u2013392","journal-title":"J Rheumatol"},{"issue":"5","key":"3682_CR3","doi-asserted-by":"publisher","first-page":"A319","DOI":"10.1016\/j.autrev.2009.11.018","volume":"9","author":"Y Berkun","year":"2010","unstructured":"Berkun Y, Padeh S (2010) Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 9(5):A319\u2013A324. doi:\n10.1016\/j.autrev.2009.11.018","journal-title":"Autoimmun Rev"},{"issue":"4","key":"3682_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1365-2370.2004.00467.x","volume":"31","author":"JL Huang","year":"2004","unstructured":"Huang JL, Yeh CC, Shaw CK, Yao TC, Chen LC, Lee TD, Kuo ML (2004) HLA-DRB1 genotyping in patients with juvenile idiopathic arthritis in Taiwan. Eur J Immunogenet 31(4):185\u2013188. doi:\n10.1111\/j.1365-2370.2004.00467.x","journal-title":"Eur J Immunogenet"},{"issue":"4","key":"3682_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jmii.2012.03.006","volume":"46","author":"CC Shen","year":"2013","unstructured":"Shen CC, Yeh KW, Ou LS, Yao TC, Chen LC, Huang JL (2013) Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan. J Microbiol, Immunol Infect = Wei mian yu gan ran za zhi 46(4):288\u2013294. doi:\n10.1016\/j.jmii.2012.03.006","journal-title":"J Microbiol, Immunol Infect = Wei mian yu gan ran za zhi"},{"issue":"6","key":"3682_CR6","first-page":"776","volume":"22","author":"JL Huang","year":"2004","unstructured":"Huang JL, Yao TC, See LC (2004) Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol 22(6):776\u2013780","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"3682_CR7","doi-asserted-by":"publisher","first-page":"e70625","DOI":"10.1371\/journal.pone.0070625","volume":"8","author":"HH Yu","year":"2013","unstructured":"Yu HH, Chen PC, Wang LC, Lee JH, Lin YT, Yang YH, Lin CP, Chiang BL (2013) Juvenile idiopathic arthritis-associated uveitis: a nationwide population-based study in Taiwan. PLoS One 8(8):e70625. doi:\n10.1371\/journal.pone.0070625","journal-title":"PLoS One"},{"key":"3682_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12969-015-0053-5","volume":"13","author":"AH Bohr","year":"2015","unstructured":"Bohr AH, Nielsen S, Muller K, Karup Pedersen F, Andersen LB (2015) Reduced physical activity in children and adolescents with juvenile idiopathic arthritis despite satisfactory control of inflammation. Pediatr Rheumatol Online J 13:57. doi:\n10.1186\/s12969-015-0053-5","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"3682_CR9","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/art.23427","volume":"58","author":"DJ Lovell","year":"2008","unstructured":"Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, Baumgartner SW, Giannini EH (2008) Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 58(5):1496\u20131504. doi:\n10.1002\/art.23427","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3682_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/nejm200003163421103","volume":"342","author":"DJ Lovell","year":"2000","unstructured":"Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck BK (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 342(11):763\u2013769. doi:\n10.1056\/nejm200003163421103","journal-title":"N Engl J Med"},{"issue":"1","key":"3682_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10067-014-2744-6","volume":"34","author":"D Windschall","year":"2015","unstructured":"Windschall D, Muller T, Becker I, Horneff G (2015) Safety and efficacy of etanercept in children with the JIA categories extended oligoarthritis, enthesitis-related arthritis and psoriasis arthritis. Clin Rheumatol 34(1):61\u201369. doi:\n10.1007\/s10067-014-2744-6","journal-title":"Clin Rheumatol"},{"issue":"11","key":"3682_CR12","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E (2004) Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 31(11):2290\u20132294","journal-title":"J Rheumatol"},{"issue":"7","key":"3682_CR13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/acr.20497","volume":"63","author":"CA Wallace","year":"2011","unstructured":"Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N (2011) American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res 63(7):929\u2013936. doi:\n10.1002\/acr.20497","journal-title":"Arthritis Care Res"},{"issue":"5","key":"3682_CR14","first-page":"1058","volume":"29","author":"HI Brunner","year":"2002","unstructured":"Brunner HI, Lovell DJ, Finck BK, Giannini EH (2002) Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol 29(5):1058\u20131064","journal-title":"J Rheumatol"},{"issue":"6","key":"3682_CR15","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.0022-202X.2005.23715.x","volume":"124","author":"M Wittmann","year":"2005","unstructured":"Wittmann M, Purwar R, Hartmann C, Gutzmer R, Werfel T (2005) Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. J Invest Dermatol 124(6):1225\u20131233. doi:\n10.1111\/j.0022-202X.2005.23715.x","journal-title":"J Invest Dermatol"},{"issue":"21","key":"3682_CR16","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1001\/jama.2011.1671","volume":"306","author":"MH Otten","year":"2011","unstructured":"Otten MH, Prince FH, Armbrust W, ten Cate R, Hoppenreijs EP, Twilt M, Koopman-Keemink Y, Gorter SL, Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW (2011) Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA 306(21):2340\u20132347. doi:\n10.1001\/jama.2011.1671","journal-title":"JAMA"},{"issue":"11","key":"3682_CR17","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1002\/art.21389","volume":"52","author":"CA Wallace","year":"2005","unstructured":"Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH (2005) Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 52(11):3554\u20133562. doi:\n10.1002\/art.21389","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3682_CR18","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3899\/jrheum.131503","volume":"41","author":"CA Wallace","year":"2014","unstructured":"Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O\u2019Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ (2014) Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors. J Rheumatol 41(6):1163\u20131170. doi:\n10.3899\/jrheum.131503","journal-title":"J Rheumatol"},{"issue":"7","key":"3682_CR19","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/rheumatology\/ket490","volume":"53","author":"T Geikowski","year":"2014","unstructured":"Geikowski T, Becker I, Horneff G (2014) Predictors of response to etanercept in polyarticular-course juvenile idiopathic arthritis. Rheumatology (Oxford, England) 53(7):1245\u20131249. doi:\n10.1093\/rheumatology\/ket490","journal-title":"Rheumatology (Oxford, England)"},{"issue":"2","key":"3682_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3899\/jrheum.120842","volume":"40","author":"N Solari","year":"2013","unstructured":"Solari N, Palmisani E, Consolaro A, Pistorio A, Viola S, Buoncompagni A, Gattorno M, Picco P, Ruperto N, Malattia C, Martini A, Ravelli A (2013) Factors associated with achievement of inactive disease in children with juvenile idiopathic arthritis treated with etanercept. J Rheumatol 40(2):192\u2013200. doi:\n10.3899\/jrheum.120842","journal-title":"J Rheumatol"},{"issue":"6","key":"3682_CR21","first-page":"919","volume":"28","author":"P Pratsidou-Gertsi","year":"2010","unstructured":"Pratsidou-Gertsi P, Trachana M, Pardalos G, Kanakoudi-Tsakalidou F (2010) A follow-up study of patients with juvenile idiopathic arthritis who discontinued etanercept due to disease remission. Clin Exp Rheumatol 28(6):919\u2013922","journal-title":"Clin Exp Rheumatol"},{"key":"3682_CR22","doi-asserted-by":"publisher","unstructured":"Guzman J, Oen K, Huber AM, Watanabe Duffy K, Boire G, Shiff N, Berard RA, Levy DM, Stringer E, Scuccimarri R, Morishita K, Johnson N, Cabral DA, Rosenberg AM, Larche M, Dancey P, Petty RE, Laxer RM, Silverman E, Miettunen P, Chetaille AL, Haddad E, Houghton K, Spiegel L, Turvey SE, Schmeling H, Lang B, Ellsworth J, Ramsey SE, Bruns A, Roth J, Campillo S, Benseler S, Chedeville G, Schneider R, Tse SM, Bolaria R, Gross K, Feldman B, Feldman D, Cameron B, Jurencak R, Dorval J, LeBlanc C, St Cyr C, Gibbon M, Yeung RS, Duffy CM, Tucker LB (2015) The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort. Ann Rheum Dis. doi:\n10.1136\/annrheumdis-2014-207164","DOI":"10.1136\/annrheumdis-2014-207164"},{"key":"3682_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13075-015-0723-1","volume":"17","author":"J Anink","year":"2015","unstructured":"Anink J, Van Suijlekom-Smit LW, Otten MH, Prince FH, van Rossum MA, Dolman KM, Hoppenreijs EP, ten Cate R, Ursu S, Wedderburn LR, Horneff G, Frosch M, Vogl T, Gohar F, Foell D, Roth J, Holzinger D (2015) MRP8\/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis. Arthritis Res Ther 17:200. doi:\n10.1186\/s13075-015-0723-1","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"3682_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s10067-011-1709-2","volume":"30","author":"CT Wu","year":"2011","unstructured":"Wu CT, Ou LS, Yeh KW, Lee WI, Huang JL (2011) Serum heat shock protein 60 can predict remission of flare-up in juvenile idiopathic arthritis. Clin Rheumatol 30(7):959\u2013965. doi:\n10.1007\/s10067-011-1709-2","journal-title":"Clin Rheumatol"},{"issue":"9","key":"3682_CR25","first-page":"1481","volume":"60","author":"D Kaminiarczyk-Pyzalka","year":"2014","unstructured":"Kaminiarczyk-Pyzalka D, Adamczak K, Mikos H, Klimecka I, Moczko J, Niedziela M (2014) Proinflammatory cytokines in monitoring the course of disease and effectiveness of treatment with etanercept (ETN) of children with oligo- and polyarticular juvenile idiopathic arthritis (JIA). Clin Lab 60(9):1481\u20131490","journal-title":"Clin Lab"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3682-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3682-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3682-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T23:38:25Z","timestamp":1502494705000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3682-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,24]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["3682"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3682-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,24]]}}}